A Phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies

Jill Gilbert, Sharyn D. Baker, M. Katherine Bowling, Louise Grochow, W. Douglas Figg, Yelena Zabelina, Ross C. Donehower, Michael A. Carducci

Research output: Contribution to journalArticlepeer-review

195 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences